Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Tattersall
R
R
Department of Clinical Diabetes, University Hospital, Nottingham, UK.
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives; D020909:Acarbose; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004435:Eating; D005944:Glucosamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000517:prevention & control; D050112:Imino Pyranoses; D014312:Trisaccharides / Q000627:therapeutic use*
D001786:Blood Glucose; D065089:Glycoside Hydrolase Inhibitors; D050112:Imino Pyranoses; D014312:Trisaccharides; C045621:miglitol; D017485:1-Deoxynojirimycin; D005944:Glucosamine; D020909:Acarbose